Waycross Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-25,429
Closed -$8.82M 75
2024
Q1
$8.82M Sell
25,429
-5,117
-17% -$1.94M 1.52% 29
2023
Q4
$14M Buy
30,546
+4,768
+18% +$2.35M 2.62% 14
2023
Q3
$12.5M Buy
25,778
+1,125
+5% +$529K 2.77% 12
2023
Q2
$11M Buy
24,653
+23,753
+2,639% +$12M 2.39% 17
2023
Q1
$437K Hold
900
0.13% 78
2022
Q4
$461K Hold
900
0.17% 75
2022
Q3
$437K Buy
+900
New +$438K 0.29% 77
2022
Q1
Sell
-1,000
Closed -$464K 83
2021
Q4
$464K Hold
1,000
0.27% 76
2021
Q3
$389K Buy
+1,000
New +$424K 0.24% 81

Other funds holding HUM

Waycross Partners's HUM Position: Q2 2024 in Review

Waycross Partners sold out of Humana (HUM) in Q2 2024, closing a stake of 25,429 shares — an estimated $8.82M sold.

Waycross Partners first reported a position in HUM in Q3 2021 and held it in 9 quarters. The position peaked at $14M in Q4 2023. 979 funds tracked by Wall St. Rank hold HUM as of Q2 2024.

  • Waycross Partners reported no remaining Humana position as of Q2 2024 after selling out during the quarter.
  • Waycross Partners sold 25,429 Humana shares in Q2 2024, an estimated $8.82M.
  • Waycross Partners first reported a position in Humana in Q3 2021 and held it in 9 quarters.
  • Waycross Partners's Humana position peaked at $14M in Q4 2023.
  • 979 funds tracked by Wall St. Rank held Humana as of Q2 2024.

Based on Waycross Partners's 13F filing for Q2 2024, filed 9 Aug 2024.